Altimmune (ALT)
(Delayed Data from NSDQ)
$7.30 USD
+0.11 (1.53%)
Updated May 3, 2024 04:00 PM ET
After-Market: $7.29 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Altimmune, Inc. [ALT]
Reports for Purchase
Showing records 61 - 75 ( 75 total )
Company: Altimmune, Inc.
Industry: Medical - Drugs
Meet Our COVID-19 Drug Developers Call Series
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Altimmune, Inc.
Industry: Medical - Drugs
NASH/CVD/Renal Companies to See and Why at Our 32nd Conference?
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Altimmune, Inc.
Industry: Medical - Drugs
Yas'' Weekly Recap of Our Key Notes and 8 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Altimmune, Inc.
Industry: Medical - Drugs
Ride the GLP1 Wave in NASH This May; Resuming with Buy
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Altimmune, Inc.
Industry: Medical - Drugs
Company: Altimmune, Inc.
Industry: Medical - Drugs
Transferring Coverage Update - Biotechnology Sector
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Altimmune, Inc.
Industry: Medical - Drugs
Final Program for Our Third Annual NASH Investor Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Altimmune, Inc.
Industry: Medical - Drugs
Program for Our Third Annual NASH Investor Conference, October 21, New York
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Altimmune, Inc.
Industry: Medical - Drugs
Altimmune Q2 Results - NasoShield News Revealed
Provider: Roth Capital Partners, Inc.
Analyst: ISAACSON J
Company: Altimmune, Inc.
Industry: Medical - Drugs
Company: Altimmune, Inc.
Industry: Medical - Drugs
Company: Altimmune, Inc.
Industry: Medical - Drugs
With Big NASH Acquisition, Altimmune Is a Player - Initiation of Coverage
Provider: Roth Capital Partners, Inc.
Analyst: ISAACSON J
Company: Altimmune, Inc.
Industry: Medical - Drugs
Company: Altimmune, Inc.
Industry: Medical - Drugs
Company: Altimmune, Inc.
Industry: Medical - Drugs
Data for 2 clinical stage candidates
Provider: JGR Capital Partners